Ellevest Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-449
| Closed | -$43.7K | – | 537 |
|
|
2023
Q1 | $43.7K | Buy |
449
+69
| +18% | +$6.71K | ﹤0.01% | 634 |
|
|
2022
Q4 | $39.3K | Sell |
380
-242
| -39% | -$25K | ﹤0.01% | 674 |
|
|
2022
Q3 | $53K | Buy |
622
+453
| +268% | +$38.6K | 0.01% | 562 |
|
|
2022
Q2 | $14K | Sell |
169
-121
| -42% | -$10K | ﹤0.01% | 816 |
|
|
2022
Q1 | $22K | Buy |
290
+82
| +39% | +$6.22K | ﹤0.01% | 717 |
|
|
2021
Q4 | $18K | Buy |
208
+36
| +21% | +$3.12K | ﹤0.01% | 734 |
|
|
2021
Q3 | $13K | Buy |
172
+61
| +55% | +$4.61K | ﹤0.01% | 767 |
|
|
2021
Q2 | $9K | Sell |
111
-85
| -43% | -$6.89K | ﹤0.01% | 777 |
|
|
2021
Q1 | $15K | Sell |
196
-254
| -56% | -$19.4K | ﹤0.01% | 711 |
|
|
2020
Q4 | $39K | Buy |
450
+333
| +285% | +$28.9K | 0.01% | 512 |
|
|
2020
Q3 | $9K | Buy |
117
+19
| +19% | +$1.46K | ﹤0.01% | 667 |
|
|
2020
Q2 | $12K | Buy |
98
+64
| +188% | +$7.84K | ﹤0.01% | 578 |
|
|
2020
Q1 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 696 |
|
|
2019
Q3 | – | Sell |
-38
| Closed | -$3K | – | 513 |
|
|
2019
Q2 | $3K | Buy |
+38
| New | +$3K | ﹤0.01% | 314 |
|